Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inscripta
MedTech
Inscripta racks up $150M round alongside commercial launch
Genomic engineering company Inscripta, a member of Fierce Medtech’s 2019 Fierce 15, recently closed a series E funding round totaling $150 million.
Andrea Park
Apr 5, 2021 3:30pm
Inscripta picks up Solana to commercialize gene-editing tools
Sep 5, 2018 1:08pm
Inscripta bags $55M+ to push forward full CRISPR suite
Feb 28, 2018 6:00am
